In focus · trending topic

Hematology

132 stories · following the connections

Aptose Exercises Early Option for CG-806 License From CrystalGenomics

By Nasdaq OMXMay 7, 2018, 11:01 AM UTC

Aptose Presents Preclinical Data on APTO-253 at 2018 AACR Annual Meeting

By Nasdaq OMXApr 17, 2018, 6:00 PM UTC

OHSU and Aptose Present New CG’806 Preclinical Data at 2018 AACR Annual Meeting

By Nasdaq OMXApr 16, 2018, 11:30 AM UTC

Aptose Presents New Preclinical Data on CG’806 Pan-FLT3/ Pan-BTK Inhibitor at 2018 AACR Annual Meeting

By Nasdaq OMXApr 16, 2018, 11:30 AM UTC

Aptose to Present New CG’806 and APTO-253 Data at the 2018 AACR Annual Meeting

By Nasdaq OMXMar 15, 2018, 11:05 AM UTC

Actinium Pharmaceuticals to Present at 30th Annual ROTH Conference

By Nasdaq OMXMar 7, 2018, 12:30 PM UTC

Aptose Biosciences Announces Exclusive License Agreement for Dual BET/Kinase Targeting Program With OHM Oncology

By Nasdaq OMXMar 7, 2018, 12:00 PM UTC

Aptose to Participate in Upcoming Investor Conferences In March 2018

By Nasdaq OMXMar 6, 2018, 12:01 PM UTC